We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Autocode Blood Glucose Monitoring System Eliminates Need for Manual Coding

By LabMedica International staff writers
Posted on 03 Feb 2010
Print article
A blood glucose monitoring system's autocoding eliminates the need for any other form of manual coding, which can reduce user error, thereby ensuring more consistent, accurate results. These meters are uniquely designed for long-term care and multiresident use settings.

Arkray, Inc. (Edina, MN,USA) has officially launched the new Assure Platinum blood glucose monitoring system. The Assure Platinum is now available for order and ready to ship in the U.S. market. The Assure Platinum blood glucose monitoring system received 510(k) clearance from the U.S. Food and Drug Demonstration (FDA) in December 2009. With high demand for an autocode system appropriate for long-term care and multipatient settings means, Arkray anticipates the Assure Platinum will quickly gain market share.

Assure Platinum is the first autocode Assure brand blood-glucose meter. The meter helps facilities meet state regulatory standards and provide better resident care. Assure Blood glucose meters are backed by the Assure Brilliance program, a comprehensive service program from the leaders of diabetes management in long-term care. Assure Brilliance provides customer service, on-site training, quality assurance/quality control (QA/QC) guidance, diabetes F-Tag advice for long-term care, a quarterly newsletter, online continuing education programs, and more to help facilities manage complex diabetes care in their facilities.

Related Links:
Arkray



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.